Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Regression Analysis. Found 20 abstracts

Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. Am J Clin Oncol. 2018 Jan;41(1):59-64.   PMCID: PMC4769977
Moore HC, Unger JM, Phillips KA, Boyle F, Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow J, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian L, Meyskens FL, Gelber RD, Hortobagyi GN, Albain KS. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. The New England journal of medicine. 2015 Mar 05;372(10):923-32.   PMCID: 4405231
Pond GR, Bellmunt J, Rosenberg JE, Bajorin DF, Regazzi AM, Choueiri TK, Qu AQ, Niegisch G, Albers P, Necchi A, Di Lorenzo G, Fougeray R, Wong YN, Sridhar SS, Ko YJ, Milowsky MI, Galsky MD, Sonpavde G. Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial design. Clin Genitourin Cancer. 2015 Feb;13(1):71-9.
Johnson ME, Zhu F, Li T, Wu H, Galloway TJ, Farma JM, Perlis CS, Turaka A. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma. J Am Acad Dermatol. 2014 Jun;70(6):1028-35.   PMCID: No NIH funding
Anderson PR, Freedman G, Nicolaou N, Sharma N, Li T, Topham N, Morrow M. Postmastectomy chest wall radiation to a temporary tissue expander or permanent breast implant--is there a difference in complication rates?. Int J Radiat Oncol Biol Phys. 2009 May;74(1):81-5.
Egleston BL, Scharfstein DO, MacKenzie E. On estimation of the survivor average causal effect in observational studies when important confounders are missing due to death. Biometrics. 2009 Jun;65(2):497-504.   PMCID: PMC2700847
Khor LY, Bae K, Al-Saleem T, Hammond EH, Grignon DJ, Sause WT, Pilepich MV, Okunieff PP, Sandler HM, Pollack A. Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10. Int J Radiat Oncol Biol Phys. 2008 Aug;71(5):1309-15.
Ruthig JC, Chipperfield JG, Bailis DS, Perry RP. Perceived control and risk characteristics as predictors of older adults' health risk estimates. J Soc Psychol. 2008 Dec;148(6):667-88.
Nguyen KH, Horwitz EM, Hanlon AL, Uzzo RG, Pollack A. Does short-term androgen deprivation substitute for radiation dose in the treatment of high-risk prostate cancer?. Int J Radiat Oncol Biol Phys. 2003 Oct;57(2):377-83.
Hanlon AL, Diratzouian H, Hanks GE. Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer. Int J Radiat Oncol Biol Phys. 2002 Jun;53(2):297-303.
Huang EH, Pollack A, Levy L, Starkschall G, Dong L, Rosen I, Kuban DA. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2002 Dec;54(5):1314-21.
Hartman TJ, Dorgan JF, Woodson K, Virtamo J, Tangrea JA, Heinonen OP, Taylor PR, Barrett MJ, Albanes D. Effects of long-term alpha-tocopherol supplementation on serum hormones in older men. The Prostate. 2001 Jan;46(1):33-8.
Hurley KE, Miller SM, Costalas JW, Gillespie D, Daly MB. Anxiety/uncertainty reduction as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer. J Womens Health Gend Based Med. 2001 Mar;10(2):189-99.
Rutledge DN, Barsevick A, Knobf MT, Bookbinder M. Breast cancer detection: knowledge, attitudes, and behaviors of women from Pennsylvania. Oncol Nurs Forum. 2001 Jul;28(6):1032-40.
von Mehren M, Arlen P, Tsang KY, Rogatko A, Meropol N, Cooper HS, Davey M, McLaughlin S, Schlom J, Weiner LM. Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. Clin Cancer Res. 2000 Jun;6(6):2219-28.
Boyd NR, Windsor RA, Perkins LL, Lowe JB. Quality of measurement of smoking status by self-report and saliva cotinine among pregnant women. Matern Child Health J. 1998 Jun;2(2):77-83.
Movsas B, Barrows MC, Steinberg SM, Middleton LP, Okunieff P, Jaffe ES, Epstein AH. Response during radiotherapy may be associated with outcome in mediastinal Hodgkin's disease. Radiat Oncol Investig. 1998 Jan;6(5):216-25.
Herold D, Hanks G, Movsas B, Hanlon A. Postradiotherapy PSA nadirs fail to support dose escalation study in patients with pretreatment PSA values < 10 ng/ml. Radiat Oncol Investig. 1997 Jan;5(1):15-9.
Sauter ER, Daly M, Linahan K, Ehya H, Engstrom PF, Bonney G, Ross EA, Yu H, Diamandis E. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):967-70.
Myers RE, Balshem AM, Wolf TA, Ross EA, Millner L. Adherence to continuous screening for colorectal neoplasia. Med Care. 1993 Jun;31(6):508-19.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Regression Analysis

Regression Analysis Aged Female Male Human Adult methods Middle Aged radiotherapy 80 and over Aged blood Prostatic Neoplasms mortality Middle Age Predictive Value of Tests Treatment Outcome US Gov't Support-PHS prevention & control Prostate-Specific Antigen Retrospective Studies Analysis of Variance Survival Analysis metabolism Follow-Up Studies Prognosis Multivariate Analysis Breast Neoplasms Risk Assessment pathology therapeutic use Conformal Radiotherapy Disease-Free Survival drug therapy radiation effects Radiation Dose-Response Relationship Mass Screening Pennsylvania Neoplasm Staging Non-US Gov't Support adverse effects therapy etiology Smoking Biological Markers administration & dosage Pregnancy genetics statistics & numerical data Incidence Biological Tumor Markers psychology Cohort Studies Time Factors Neoplasm Invasiveness Colorectal Neoplasms Motivation Age Factors Risk Factors Radiotherapy Dosage analysis epidemiology immunology chemistry Combined Modality Therapy Drug Dose-Response Relationship Prospective Studies surgery Vitamin E toxicity Prolactin radiography Demography Salvage therapy Merkel Cell Carcinoma Prior perioperative chemotherapy Mononuclear Leukocytes Epidemiologic Research Design Salvage Therapy Proportional Hazards Models Pancreatic Neoplasms immune function Rectum Tumor Biomarkers Cross-Sectional Studies Hip Fractures Radiometry Premenopause Intensity-Modulated Radiotherapy Enzyme-Linked Immunosorbent Assay biosynthesis Merkel cell carcinoma Algorithms physiopathology Sample Size Statistical Data Interpretation Adenocarcinoma Occult Blood Ovariectomy Immunoglobulin G Drug Therapy Pedigree Reoperation Biometry CD80 Antigens Cholesterol Perioperative Care Adolescent Attitudes Knowledge-Practice US Gov't Support-Non-PHS Testosterone Genetic Counseling New Jersey T-Lymphocytes Pregnancy Complications Mammaplasty Androgen Antagonists absolute lymphocyte count Hodgkin Disease Antineoplastic Combined Chemotherapy Protocols Fluoroimmunoassay Carcinoembryonic Antigen Mammography Gonadotropin-Releasing Hormone Postoperative Complications Probability diagnosis Truth Disclosure Adjuvant Chemotherapy Treatment Failure Breast Self-Examination chemically induced Hematologic Diseases Nipples enzymology Goserelin skin cancer Linear Models Lymphocyte Count Radioimmunoassay Biopsy Cotinine Tumor-Infiltrating Lymphocytes Avipoxvirus Internal-External Control Breast Implants utilization Cyclic AMP-Dependent Protein Kinase Type I Thoracic Wall Esthetics Manitoba
Last updated on Wednesday, February 05, 2020